RAFAEL HOLDINGS, INC. Additional Paid in Capital, Common Stock
RAFAEL HOLDINGS, INC. (RFL) had Additional Paid in Capital, Common Stock of $323.23 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-06-11
- 2026-04-30: Additional Paid in Capital, Common Stock $323.23M.
- 2026-01-31: Additional Paid in Capital, Common Stock $323.08M.
- 2025-10-31: Additional Paid in Capital, Common Stock $322.73M.
- 2025-07-31: Additional Paid in Capital, Common Stock $322.16M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-04-30 | $323.23M 10-Q · filed 2026-06-11 |
| 2026-01-31 | $323.08M 10-Q · filed 2026-03-16 |
| 2025-10-31 | $322.73M 10-Q · filed 2025-12-12 |
| 2025-07-31 | $322.16M 10-Q · filed 2026-06-11 |
| 2025-04-30 | $296.65M 10-Q · filed 2025-06-11 |
| 2025-01-31 | $280.83M 10-Q · filed 2025-03-14 |
| 2024-10-31 | $280.36M 10-Q · filed 2024-12-11 |
| 2024-07-31 | $280.05M 10-K · filed 2025-10-29 |
| 2024-04-30 | $279.64M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $266.16M 10-Q · filed 2024-03-14 |
| 2023-10-31 | $265.49M 10-Q · filed 2023-12-14 |
| 2023-07-31 | $264.01M 10-Q · filed 2024-06-14 |
| 2022-07-31 | $262.02M 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |